These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2885419)

  • 21. Asperlicin: a unique nonpeptide cholecystokinin antagonist.
    Zucker KA; Adrian TE; Zdon MJ; Ballantyne GH; Modlin IM
    Surgery; 1987 Aug; 102(2):163-70. PubMed ID: 2441481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in the chemistry of cholecystokinin receptor ligands (agonists and antagonists).
    de Tullio P; Delarge J; Pirotte B
    Curr Med Chem; 1999 Jun; 6(6):433-55. PubMed ID: 10213792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholecystokinin antagonists. Synthesis and biological evaluation of 3-substituted 1,4-benzodiazepin-2-amines.
    Bock MG; DiPardo RM; Evans BE; Rittle KE; Freidinger RM; Chang RS; Lotti VJ
    J Med Chem; 1988 Jan; 31(1):264-8. PubMed ID: 3336026
    [No Abstract]   [Full Text] [Related]  

  • 24. Novel 1,5-benzodiazepines as CCK-B ligands. Effect of aryl-carbamic substituents at the C-3 position together with halogen substitution on the benzo-fused ring.
    Tranquillini ME; Cassarà PG; Corsi M; Curotto G; Donati D; Finizia G; Pentassuglia G; Polinelli S; Tarzia G; Ursini A; van Amsterdam FT
    Arch Pharm (Weinheim); 1997 Nov; 330(11):353-7. PubMed ID: 9431027
    [No Abstract]   [Full Text] [Related]  

  • 25. Hybrid cholecystokinin-A antagonists based on molecular modeling of lorglumide and L-364,718.
    van der Bent A; Blommaert AG; Melman CT; IJzerman AP; van Wijngaarden I; Soudijn W
    J Med Chem; 1992 Mar; 35(6):1042-9. PubMed ID: 1552499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hybrid cholecystokinin (CCK) antagonists: new implications in the design and modification of CCK antagonists.
    Kerwin JF; Nadzan AM; Kopecka H; Lin CW; Miller T; Witte D; Burt S
    J Med Chem; 1989 Apr; 32(4):739-42. PubMed ID: 2704023
    [No Abstract]   [Full Text] [Related]  

  • 27. Benzodiazepine gastrin and brain cholecystokinin receptor ligands: L-365,260.
    Bock MG; DiPardo RM; Evans BE; Rittle KE; Whitter WL; Veber DE; Anderson PS; Freidinger RM
    J Med Chem; 1989 Jan; 32(1):13-6. PubMed ID: 2909725
    [No Abstract]   [Full Text] [Related]  

  • 28. Possible involvement of the CCK receptor in the benzodiazepine antagonism to CCK in the mouse brain.
    Sugaya K; Matsuda I; Kubota K
    Jpn J Pharmacol; 1987 Jan; 43(1):67-71. PubMed ID: 2883334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and evaluation of asperlicin analogues as non-peptidal cholecystokinin-antagonists.
    Lattmann E; Billington DC; Poyner DR; Howitt SB; Offel M
    Drug Des Discov; 2001; 17(3):219-30. PubMed ID: 11469752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative structure-activity relationship studies on cholecystokinin antagonists.
    Gupta SP
    Curr Pharm Des; 2002; 8(2):111-24. PubMed ID: 11812253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists.
    Huang SC; Zhang L; Chiang HC; Wank SA; Maton PN; Gardner JD; Jensen RT
    Am J Physiol; 1989 Jul; 257(1 Pt 1):G169-74. PubMed ID: 2473653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholecystokinin antagonists: (R)-tryptophan-based hybrid antagonists of high affinity and selectivity for CCK-A receptors.
    Kerwin JF; Wagenaar F; Kopecka H; Lin CW; Miller T; Witte D; Stashko M; Nadzan AM
    J Med Chem; 1991 Dec; 34(12):3350-9. PubMed ID: 1766000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the binding of [3H]L-365,260: a new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligand.
    Chang RS; Chen TB; Bock MG; Freidinger RM; Chen R; Rosegay A; Lotti VJ
    Mol Pharmacol; 1989 Jun; 35(6):803-8. PubMed ID: 2733696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1,4-Benzodiazepine peripheral cholecystokinin (CCK-A) receptor agonists.
    Sherrill RG; Berman JM; Birkemo L; Croom DK; Dezube M; Ervin GN; Grizzle MK; James MK; Johnson MF; Queen KL; Rimele TJ; Vanmiddlesworth F; Sugg EE
    Bioorg Med Chem Lett; 2001 May; 11(9):1145-8. PubMed ID: 11354363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of strain difference in behavior to Cholecystokinin (CCK) receptor mediated drugs in PVG hooded and Sprague-Dawley rats using elevated plus-maze test apparatus.
    Farook JM; Zhu YZ; Wang Q; Moochhala SM; Lee L; Wong PT
    Neurosci Lett; 2004 Apr; 358(3):215-9. PubMed ID: 15039119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peptide/benzodiazepine hybrids as ligands of CCK(A) and CCK(B) receptors.
    Escherich A; Lutz J; Escrieut C; Fourmy D; van Neuren AS; Müller G; Schafferhans A; Klebe G; Moroder L
    Biopolymers; 2000-2001; 56(2):55-76. PubMed ID: 11592053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combinatorial solid phase synthesis of multiply substituted 1,4-benzodiazepines and affinity studies on the CCK2 receptor (part 1).
    Lattmann E; Billington DC; Poyner DR; Arayarat P; Howitt SB; Lawrence S; Offel M
    Drug Des Discov; 2002; 18(1):9-21. PubMed ID: 12375632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel glutamic acid derived cholecystokinin receptor ligands.
    Freidinger RM; Whitter WL; Gould NP; Holloway MK; Chang RS; Lotti VJ
    J Med Chem; 1990 Feb; 33(2):591-5. PubMed ID: 2299627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C-terminal anthranoyl-anthranilic acid derivatives and their evaluation on CCK receptors.
    Varnavas A; Lassiani L; Luxich E; Valenta V
    Farmaco; 2000 Apr; 55(4):293-302. PubMed ID: 10966161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholecystokinin peptidomimetics as selective CCK-B antagonists: design, synthesis, and in vitro and in vivo biochemical properties.
    Blommaert AG; Weng JH; Dorville A; McCort I; Ducos B; Durieux C; Roques BP
    J Med Chem; 1993 Oct; 36(20):2868-77. PubMed ID: 8411002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.